Last night, Dr. Matthew Tripp, Chief Scientific Officer of Synergy/NSP, spoke to a large number of listeners on this month's Cardio Call. Dr. Tripp had some important and fascinating things to say about our company's research and development plans and our mission to reverse chronic disease. Here are a few of the highlights:
Click to listen to the full Cardio Call with Dr. Tripp.
---------------------------------------------------------------------------------------
"After meeting with the top management of the [Synergy/NSP], what I recognized was that their vision and my passion are very well aligned. My passion is to make a difference in the world. You might call it a personal mission, if you will. It’s not religion based, it’s just seeing a great level of chronic illness in the world and asking ‘how can I make a difference’ and ‘how can we work together.’ That’s what impressed me about the folks at Synergy and Nature’s Sunshine. They cared very much. They wanted to leverage what they had to do bigger, better things."
"We are building a molecular and cellular biology lab for discovery, a chemistry lab and a clinic. We’ll be running human clinical trials on our discoveries and also on many of our fine products to demonstrate their clinical efficacy. We’ll have state-of-the-art instrumentation. We’ll be developing our own intellectual property. It’s a full blown discovery and development project."
Click to listen to the full Cardio Call with Dr. Tripp.
---------------------------------------------------------------------------------------
Our goal: is saving one heart at a time. by following Dan Hammer's findings and sharing with others who would benefit.
Call me (Scott Hancock) for more information.
Call me (Scott Hancock) for more information.
Mobile: 1-801-830-8316
No comments:
Post a Comment